These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 23617566)

  • 1. Lithium's role in neural plasticity and its implications for mood disorders.
    Gray JD; McEwen BS
    Acta Psychiatr Scand; 2013 Nov; 128(5):347-61. PubMed ID: 23617566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
    Machado-Vieira R
    J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids and lithium in adult hippocampal neurogenesis.
    Boku S; Nakagawa S; Koyama T
    Vitam Horm; 2010; 82():421-31. PubMed ID: 20472150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.
    Silva R; Mesquita AR; Bessa J; Sousa JC; Sotiropoulos I; Leão P; Almeida OF; Sousa N
    Neuroscience; 2008 Mar; 152(3):656-69. PubMed ID: 18291594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.
    Einat H; Manji HK
    Biol Psychiatry; 2006 Jun; 59(12):1160-71. PubMed ID: 16457783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system.
    Zarate CA; Du J; Quiroz J; Gray NA; Denicoff KD; Singh J; Charney DS; Manji HK
    Ann N Y Acad Sci; 2003 Nov; 1003():273-91. PubMed ID: 14684452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium treatment prevents stress-induced dendritic remodeling in the rodent amygdala.
    Johnson SA; Wang JF; Sun X; McEwen BS; Chattarji S; Young LT
    Neuroscience; 2009 Sep; 163(1):34-9. PubMed ID: 19501634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview.
    Bortolozzi A; Fico G; Berk M; Solmi M; Fornaro M; Quevedo J; Zarate CA; Kessing LV; Vieta E; Carvalho AF
    Pharmacol Rev; 2024 May; 76(3):323-357. PubMed ID: 38697859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Homeostatic Synaptic Plasticity for Treatment of Mood Disorders.
    Kavalali ET; Monteggia LM
    Neuron; 2020 Jun; 106(5):715-726. PubMed ID: 32497508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.
    Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R
    Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium.
    Kilts CD
    J Clin Psychiatry; 2000; 61 Suppl 9():41-6. PubMed ID: 10826660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding the intracellular signaling pathways affected by mood disorder treatments.
    Coyle JT; Duman RS
    Neuron; 2003 Apr; 38(2):157-60. PubMed ID: 12718851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders.
    Puglisi-Allegra S; Ruggieri S; Fornai F
    Transl Psychiatry; 2021 Jul; 11(1):366. PubMed ID: 34226487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lithium ion: a foundation for psychopharmacological specificity.
    Soares JC; Gershon S
    Neuropsychopharmacology; 1998 Sep; 19(3):167-82. PubMed ID: 9653704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania.
    Cechinel-Recco K; Valvassori SS; Varela RB; Resende WR; Arent CO; Vitto MF; Luz G; de Souza CT; Quevedo J
    J Psychopharmacol; 2012 Dec; 26(12):1594-604. PubMed ID: 23076832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
    Manji HK; Duman RS
    Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton magnetic resonance spectroscopy changes after lithium treatment. Systematic review.
    Szulc A; Wiedlocha M; Waszkiewicz N; Galińska-Skok B; Marcinowicz P; Gierus J; Mosiolek A
    Psychiatry Res Neuroimaging; 2018 Mar; 273():1-8. PubMed ID: 29414126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
    Gray NA; Zhou R; Du J; Moore GJ; Manji HK
    J Clin Psychiatry; 2003; 64 Suppl 5():3-17. PubMed ID: 12720479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.